Zepp Health Corporation ZEPP NYSE

Zepp Health Corporation (ZEPP) generated $-24.39M in operating cash flow for fiscal year 2024. After capital expenditures of $1.49M, free cash flow was $-25.88M.

Free cash flow margin was -14.2% of revenue. Cash conversion ratio was 0.32x, suggesting some earnings are non-cash.

The company returned $2.28M in share buybacks to shareholders during the period.

Criteria supported by this page:

• HEALTH (33/100, Fail) — weak cash flow raises concerns about debt servicing
• MOAT (48/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
• INCOME (10/100) — Cash conversion ratio was 0.32x suggests some earnings are non-cash items

Overall SharesGrow Score: 26/100 with 0/7 criteria passed.